Hepcinat Tablet (Sofosbuvir) – Generic HCV NS5B Polymerase Inhibitor
Hepcinat (Sofosbuvir) (generic equivalent to Sovaldi) is a prescription direct-acting antiviral (DAA) used to treat Chronic Hepatitis C Virus (HCV) infection. Modern DAA therapies like Hepcinat deliver cure rates exceeding 95% in most HCV genotypes.
Composition: Sofosbuvir (400mg)
Treatment Course: Typically 8–12 weeks.
Manufacturer: Natco Pharma Ltd
Prescription-only antiviral. Use under the supervision of a hepatologist or infectious disease specialist. Baseline genotyping and viral load testing required before starting treatment.
Composition Sofosbuvir (400mg) + Daclatasvir (60mg)
Dosage Form Tablets
Generic Name Sofosbuvir and Daclatasvir
Indication Hepatitis C
Manufacturer Natco Pharma Ltd
Packaging 28 tablets in 1 bottle
RxMed Kart's sole intention is to ensure that its consumers get expert-reviewed, accurate, and trustworthy information. However, the information contained herein should NOT use as a substitute for a qualified physician's advice. The information provided here is for informational purposes only. This may not cover all possible side effects, drug interactions, or warnings or alerts. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.